Neratinib had an acceptable safety profile and was generally well tolerated as a continual oral daily dose up to 240 mg. Diarrhea of any grade was the most common TEAE and was reported for 20 subjects (95.2%).
Neratinib had an acceptable safety profile and was generally well tolerated as a continual oral daily dose up to 240 mg. Diarrhea of any grade was the most common TEAE and was reported for 20 subjects (95.2%).